Acute Migraine

24 registered clinical trials studyying Acute Migraine.

Status	Trial	Sponsor	Phase
Terminated	A Study of K-645 in the Treatment of Multiple Migraine Attacks NCT07116499	Kallyope Inc.	Phase 2
Completed	A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migr NCT06848075	Kallyope Inc.	Phase 2
Completed	A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Parti NCT05371652	Pfizer	Phase 3
Completed	Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine NCT04574362	Pfizer	Phase 3
Completed	Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine NCT04408794	Pfizer	Phase 2 / Phase 3
Completed	Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in Korean NCT04218162	IlDong Pharmaceutical Co Ltd	Phase 3
Terminated	Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents NCT04089761	Theranica	N/A
Completed	A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine NCT04153409	Lateral Pharma Pty Ltd	Phase 2
Completed	The RIME Study - Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migrain NCT03631550	Neurolief Ltd.	N/A
Terminated	Migraine Treatment With Nerivio Migra Neurostimulation Device NCT03076515	Theranica	N/A
Completed	Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine NCT02745392	Zosano Pharma Corporation	Phase 2 / Phase 3
Completed	Lasmiditan Compared to Placebo in the Acute Treatment of Migraine: NCT02439320	Eli Lilly and Company	Phase 3
Completed	DFN-02 Open Label Safety Study in Patients With Acute Migraine NCT02279082	Dr. Reddy's Laboratories Limited	Phase 3
Terminated	Chordate System S020 Acute Migraine Clinical Investigation NCT02185703	Chordate Medical	N/A
Completed	Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine NCT01973205	Novartis	Phase 3
Completed	Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Mig NCT02684409	NuPathe Inc.	Phase 1
Terminated	PBASE-system Acute Migraine Clinical Investigation NCT01680029	Chordate Medical	N/A
Completed	Intravenous Dexketoprofen and Paracetamol in the Treatment of Headache Caused by Acute Migraine Attack NCT01730326	Pamukkale University	Phase 4
Unknown	The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute Migraine NCT01228552	Behar, Caren, M.D.	Phase 3
Completed	Valproate Versus Ketorolac Versus Metoclopramide NCT01267864	Montefiore Medical Center	Phase 4
Terminated	Treximet Migraine Brain Imaging Research Study NCT01112553	Mclean Hospital	—
Completed	A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087) NCT00894556	Organon and Co	Phase 3
Completed	Transcranial Direct Current Stimulation for Migraine Attack NCT01358279	Seoul National University Hospital	N/A
Completed	Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine NCT01276977	California Medical Clinic for Headache	N/A